-
UroGen Pharma's (URGN) "Buy" Rating Reiterated at D. Boral Capital
Source: Buzz FX / 10 Mar 2025 10:52:17 America/New_York
UroGen Pharma's (URGN) "Buy" Rating Reiterated at D. Boral Capital Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by e
Read more...